Clinical trial

Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes

NCT03284970

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-08-23

PhaseN/A

Study timeline

Study start (actual)2017-08-23Date precision: day

Registry last updated2018-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-Remitting Multiple Sclerosisunresolved

Interventions

Sponsors & collaborators

EMD Serono Research & Development Institute, Inc.lead sponsor

Merck KGaA, Darmstadt, Germanycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03284970 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.